Back to today’s briefing

Story perspectives

WADA Investigates Ozempic for Potential Doping Ban

1/13/2025

32 7

Summary

Story summary

The World Anti-Doping Organization (WADA) is closely examining semaglutide, known as Ozempic and Wegovy, for possible addition to its banned substances list. Over the next two years, WADA will evaluate how this diabetes medication, now a weight-loss sensation, affects athletic performance and health, amid rising concerns and market shortages.

1 of 1

Story summary

The World Anti-Doping Organization (WADA) is closely examining semaglutide, known as Ozempic and Wegovy, for possible addition to its banned substances list. Over the next two years, WADA will evaluate how this diabetes medication, now a weight-loss sensation, affects athletic performance and health, amid rising concerns and market shortages.